宫颈病变的早期筛查及绝经妇女异常筛查结果的临床分析-现代医学

宫颈病变的早期筛查及绝经妇女异常筛查结果的临床分析

单位：南京市中心医院妇科, 江苏南京 210018

分类号：R711.74

出版年·卷·期（页码）：2018·37·第九期（1002-1006）

摘要：

目的：初步探讨绝经妇女宫颈病变早期筛查的必要性和策略。方法：2015年1月至2017年12月间在我院接受宫颈液基薄层细胞学检查（TCT）者共计7 205例，高危型人乳头瘤病毒（HR-HPV）检测者2 999例。其中1 915例绝经妇女行TCT检查，1 095例同时行HR-HPV检测。103例绝经妇女进一步行阴道镜下宫颈多点活检。结果：绝经妇女TCT阳性率（5.01%）显著低于育龄女性（6.62%）。不同年龄组HR-HPV检测的阳性率有显著性差异。绝经妇女异常阴道流血和接触性出血的发生率显著低于育龄女性，宫颈光滑的比率显著高于育龄女性。TCT级别越高，高级别宫颈病变的检出率越高。TCT （-） HPV （+）组、TCT （+） HPV （-）组和TCT （+） HPV （+）组患者宫颈高级别病变的检出率分别为11.8%（6/51）、33.3%（6/18）和58.8%（20/34），有显著性差异。结论：绝经妇女应定期行宫颈筛查以早期发现宫颈病变，宫颈TCT和HR-HPV联合筛查适用于绝经妇女。

Objective: To investigate the necessities and strategies of early screening for cervical lesions among postmenopausal women. Methods: Thinprep cytology test (TCT) in 7 205 women was done in our hospital from January 2015 to December 2017. High-risk human papillomavirus (HR-HPV) test was done in 2 999 women. Among all these persons, there were 1 915 postmenopausal women who were given TCT. 1 095 cases received both TCT and HR-HPV test. The cervical multi-point biopsy under colposcopy was performed in 103 patients for further test. Results: The positive rate of TCT was significantly lower in postmenopausal group than that in premenopausal group (5.01% vs 6.62%). There were significant differences of HR-HPV infection rates among different age groups. Postmenopausal women were less likely to have vaginal bleeding or cervical contactive bleeding and were more likely to have smooth cervical appearance than premenopausal women. The detection rate of high-grade cervical lesion increased with the severity of TCT. In TCT(-)HPV(+)group, TCT(+)HPV(-)group and TCT(+)HPV(+)group, the detection rate of high-grade cervical lesion was 11.8%(6/51), 33.3%(6/18) and 58.8%(20/34) respectively, with significant difference. Conclusion: It is important for postmenopausal women to receive regular cervical screening for early diagnosis. Co-test of TCT and HR-HPV is appropriate for postmenopausal women.

参考文献：

[1] 程敏,吴令英,章文华,等.215例老年宫颈癌的临床分析[J].中华肿瘤杂志,2009,31(5):388-391.
[2] COLEMAN C N,MINSKY B D.The verdict is in:the time for effective solutions to the global cancer burden is now[J].Lancet Oncol,2015,16(10):1146-1147.
[3] 郝敏,蔺莉.绝经后妇女宫颈上皮内瘤变Ⅱ级及以上患者临床特点分析[J].中国微创外科杂志,2017,17(2):155-158.
[4] 黄恩杰,罗新.中国大陆宫颈细胞学筛查技术实施的现状及缺憾[J].中国计划生育和妇产科,2016,8(9):4-7.
[5] 王爱春,顾依群,王军,等.TCT及HC2-HPV-DNA检测对绝经后妇女宫颈癌筛查的应用价值评估[J].现代肿瘤医学,2011,19(1):133-135.
[6] SANJOSE S D,QUINT W G,ALEMANY L,et al.Human papilloma-virus genotype attribution in invasive cervical cancer:a retrospective cross-sectional worldwide study[J].Lancet Oncol,2010,11(11):1013-1014.
[7] 陈娟,麻全慧,施建丰,等.南京地区2387例有性生活女性的宫颈脱落细胞高危HPV检测分析[J].山东医药,2014,54(23):70-72.
[8] 孙静波,朱凤琴.宫颈人乳头瘤病毒联合液基细胞学检测在宫颈疾病筛查中的价值分析[J].安徽医药,2016,20(6):1119-1122.
[9] CHELMOW D.Cervical cancer screening and prevention[J].Obstet Gynecol,2016,127(1):1-20.
[10] 唐雪莲,梁绮文,王芳,等.深圳市社区妇女与妇科门诊患者宫颈癌认知及筛查情况调查[J].东南大学学报(医学版),2013,32(4):449-452.
[11] ELIT L.Role of cervical screening in older women[J].Maturitas,2014,79(4):413-420.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录